ADMISSIBILITY OF HEMP CROP OTHER THAN FIBROUS IN POLAND
2022, 95, Numer 1
Data publikacji
Model publikowania
Rodzaj licencji
Dziedzina
Dyscyplina
Język publikacji
Pliki do pobrania
PDF 311 KB
Liczba wyświetleń:167
Liczba pobrań:84
Cytowania Crossref:0
Wynik Altmetric:0
Abstrakt
Implementation in the Polish legal system of the amendment of the Act on Counteracting Drug Addiction on 7 May 2022 allowed for a possibility of cultivating in Poland hemp other than fibrous for the needs of the pharmaceutical industry. The paper discusses the path that has led from the legalization of cannabis and its products to a gradual change of attitude both in international and national legislation. The aim of the study is also to familiarize the reader with the requirements the Polish legislator has placed on entities that intend to grow hemp other than fibrous for the production of pharmaceutical raw material.
Bibliografia
Andre C.M., Hausman J.F., Guerriero G., Cannabis sativa: The plant of the thousand and one molecules, "Frontiers in Plant Science" 2016
https://doi.org/10.3389/fpls.2016.00019
Ashton C.H., Pharmacology and effects of cannabis: A brief review, "The British Journal of Psychiatry" 2001, Vol. 178, issue 2
https://doi.org/10.1192/bjp.178.2.101
Bołtryk P., Kryminologiczne i prawne aspekty posiadania narkotyków w Polsce (na przykładzie pochodnych konopi innych niż włókniste), Białystok 2014
Burnstein S., Cannabidiol (CBD) and its analogs: A review of their effects on inflammation, "Bioorganic & Medicinal Chemistry" 2015, No. 5
https://doi.org/10.1016/j.bmc.2015.01.059
Dzierżanowski T., Kanabinoidy - możliwości zastosowania w medycynie paliatywnej, "Medycyna Paliatywna" 2018, No. 10
https://doi.org/10.5114/pm.2018.77198
Englund A., Stone J.M., Morrison P.D., Cannabis in the arm: What can we learn from intravenous cannabinoid studies?, "Current Pharmaceutical Design" 2012, Vol. 18, issue 32
https://doi.org/10.2174/138161212802884618
Gała P., Bariery prawne twórczej hodowli nowych odmian konopi włóknistych w Polsce, (in:) E. Całka, A. Jakubecki, M. Nazar, A. Niewęgłowski, R. Poździk (red.), In varietate concordia. Księga jubileuszowa Profesora Ryszarda Skubisza, Warszawa 2022
Hill A.J., Williams C.M., Whalley B.J., Stephens G.J., Phytocannabinoids as novel therapeutic agents in CNS disorders, "Pharmacology & Therapeutic" 2012, Vol. 133, issue 1
https://doi.org/10.1016/j.pharmthera.2011.09.002
Iseger T., Bossong M., A systematic review of the antipsychotic properties of cannabidiol in humans, "Schizophrenia Research" 2015, No. 162
https://doi.org/10.1016/j.schres.2015.01.033
Kuna M., Warunki medycznego zastosowania marihuany w Polsce - aspekty prawa administracyjnego, "Przegląd Prawa Administracyjnego" 2019, No. 2
https://doi.org/10.17951/ppa.2019.2.81-93
Pacher P., Batkai S., Kunos G., The endocannabinoid system as an emerging target of pharmacotherapy, "Pharmacological Reviews" 2006, No. 58
https://doi.org/10.1124/pr.58.3.2
Rathi V. et al., Legality of worldwide cannabis use and associated economic benefits, (in:) T. Belwal, N.C. Belwal (eds.), Revolutionizing the potential of hemp and its products in changing the global economy, Springer 2022
https://doi.org/10.1007/978-3-031-05144-9_3
Strzelczyk M., Kaniewski R., Konopie siewne Cannabis sativa L. - jeden z najstarszych gatunków roślin użytkowych, "Postępy Fitoterapii" 2021, No. 1
https://doi.org/10.25121/PF.2021.22.1.53
Wagner H., Urlich-Merzenich G., Synergy research: Approaching a new generation of phytopharmaceuticals, "Phytomedicine" 2009, Vol. 16
https://doi.org/10.1016/j.phymed.2008.12.018